As of April 2024 Kiniksa Pharmaceuticals has a market cap of $1.24 Billion. This makes Kiniksa Pharmaceuticals the world's 4815th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.24 B | 1.19% |
2023 | $1.23 B | 18.45% |
2022 | $1.04 B | 28.46% |
2021 | $0.81 B | -32.59% |
2020 | $1.20 B | 97.97% |
2019 | $0.60 B | -56.29% |
2018 | $1.39 B |
On Apr 23rd, 2024 the market cap of Kiniksa Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.59 B | -52.67% | ๐บ๐ธ USA |